Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20150518022306N3
IRCT20150518022306N3
Recruiting
Phase 3

the comparison of Effect of calcitriol and cholecalciferol on cardiac biomarkers in patients undergoing elective percutaneous coronary intervention, a randomized controlled study

Shiraz University of Medical Sciences0 sites180 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shiraz University of Medical Sciences
Enrollment
180
Status
Recruiting
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •All patients diagnosed with Coronary artery disease who hospitalized due to performing elective percutaneous Coronary Intervention (angioplasty with stent)
  • •Vitamin D level of less than 30 ng/m

Exclusion Criteria

  • •patients with myocardial infarction or history of coronary artery bypass graft in last 3 months
  • •patients with history of vitamin D supplementation in the last 1 month prior to hospitalization
  • •patients with history of unsuccessful PCI

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Effect of Calciterol and Cinacalcate on hyperparathyroidism
IRCT20190702044076N1Shahre-kord University of Medical Sciences60
Completed
Phase 3
Evaluation of effect of different type of vitamin D on biochemical markers of osteopenia of Prematurity
IRCT20111206008307N28Tabriz University of Medical Sciences70
Completed
Phase 2
Evaluation of the effect of calcitriol supplementation on diabetes control and its complications in hyperlipidemic patients with type 2 diabetes mellitus, Shiraz, 2009
IRCT138806282480N1Shiraz university of medical sciences70
Completed
Phase 2
Effect of oral calcitriol pulse therapy in comparison with oral daily calcitriol method in hemodiyalis paitientsSecondary hyperparathyroidism of renal origin.Secondary hyperparathyroidism of renal originGB90.4
IRCT20111024007892N10Mashhad University of Medical Sciences20
Completed
Not Applicable
Comparative study on the effects of calcium antagonists on central blood pressureChronic kidney disease
JPRN-UMIN000003323Saitama Medical Univeristy60